Filing Details
- Accession Number:
- 0001543209-18-000001
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-05 12:04:22
- Reporting Period:
- 2018-01-03
- Accepted Time:
- 2018-01-05 12:04:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1105533 | Argos Therapeutics Inc | ARGS | Pharmaceutical Preparations (2834) | 562110007 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1543209 | A. Charles Nicolette | Argos Therapeutics, Inc. 4233 Technology Drive Durham NC 27704 | Cso And Vice President Of R&D | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-01-03 | 92,001 | $0.16 | 500,240 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Shares reported represent an amount sold to cover the tax liabilities of the reporting person pursuant to a 10b5-1 sales instruction related to a restricted stock award agreement dated August 30, 2017. Acquisition of the restricted stock was previously reported in Table I of the reporting person's Form 4 on August 31, 2017.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $0.1581 to $0.186 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
